AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06144099 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: prothrombin complex concentrate
Description: prothrombin complex concentrate administration
Study NCT04566887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: Administered as 100mg tablets.
Study NCT04566887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R-CHOP chemotherapy
Description: R-CHOP chemotherapy
Study NCT06092281 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Patients after ESD need to complete a questionnaire on compliance-related education before discharge. The questionnaire includes the following information:~1. General information about the patient (e.g., education level, place of residence, economic status, employment status, family history of neoplasms, whether the patient or immediate family member has a medical background, number of previous endoscopic examinations, etc.)~2. Awareness of follow-up examinations (e.g., knowledge about the timing of the first follow-up, the process of follow-up examinations, related educational issues about follow-up, etc.)~3. Awareness of the disease (self-perceived tumor is benign or malignant, whether lifestyle changes are required, etc.)
Study NCT06092281 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire without compliance-related education
Description: Patients after ESD need to complete a questionnaire without compliance-related education before discharge. The questionnaire includes only general information about the patient (e.g., education level, place of residence, economic status, employment status, family history of neoplasms, whether the patient or immediate family member has a medical background, number of previous endoscopic examinations, etc.)
Study NCT00669123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chondroitin sulphate
Description: Chondroitin sulphate 800 mg/day
Study NCT00669123 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04997356 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hostile Bias Modification Training
Description: Volunteers will complete a novel computer-based hostile bias modification training where they are instructed to respond to word fragments (words with missing letters) based on whether the word fragments can be completed to form aggressive or positive/neutral words. They will refrain from making words that can only form aggressive words.
Study NCT04997356 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Other training
Description: Volunteers will complete a computer-based task where they are instructed to respond to word fragments (words with missing letters) regardless of whether the fragments can make hostile or ambiguous words.
Study NCT04872140 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low phytate pea powder
Description: Exercise performance with low phytate pea powder
Study NCT04872140 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Regular pea powder
Description: Exercise performance with regular pea powder
Study NCT04872140 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (maltodextrin)
Description: Exercise performance with placebo (maltodextrin)
Study NCT05563155 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone 24 mg
Description: Dexamethasone 24 mg on day 1 after surgery.
Study NCT05563155 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet given on day 1 after surgery.
Study NCT04734561 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training group
Description: Participants will perform an inspiratory muscle training including warm-up, recovery between intervals and return to calm.
Study NCT04734561 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Inspiratory muscle training placebo group
Description: Participants will perform an inspiratory muscle training including warm-up, recovery between intervals and return to calm.
Study NCT04734561 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory + expiratory muscle training group
Description: Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.
Study NCT04734561 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Inspiratory + expiratory muscle training placebo group
Description: Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.
Study NCT04756375 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Use of virtual reality in the management of sickle cell patients with VOS
Study NCT04756375 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Usual management of sickle cell patients with VOS
Study NCT05588570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAT
Description: Treatment includes 12 sessions: 2 caregiver teach sessions, 4 caregiver coach sessions in the child-directed interaction (CDI) phase, and 6 caregiver coach sessions in the DADS (Describe situation, Approach situation, give Direct command for child to join situation, provide Selective attention based on child's performance) phase. Throughout the 12 sessions, caregivers are coached through exposures in which the child is given the opportunity to slowly encounter anxiety-provoking factors. In the first session, caregivers are provided psychoeducation on anxiety and parenting practices and taught PRIDE (praise, reflect, imitate, describe, enjoy) skills, which are aimed at increasing approach behaviors and decreasing avoidant behaviors. In the CDI phase, caregivers are coached live via Bluetooth headset through the PRIDE and active ignoring skills. In the last 5 sessions, caregivers are coached through the DADS protocol while working up the Fear Hierarchy with the child.
Study NCT06109480 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High definition transcranial direct current stimulation
Description: tDCS is described as a non-invasive form of brain stimulation that uses a low-intensity, constant current applied directly to the head through scalp electrodes.
Study NCT06109480 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham High definition transcranial direct current stimulation
Description: Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.
Study NCT06109480 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electroconvulsive therapy device
Description: ECT induces brief generalized epileptic seizures by electric current to stimulate the forehead under general anesthesia
Study NCT06109480 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: electroconvulsive therapy device
Description: ECT induces brief generalized epileptic seizures by electric current to stimulate the forehead under general anesthesia
Study NCT06109480 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: electroconvulsive therapy device
Description: ECT induces brief generalized epileptic seizures by electric current to stimulate the forehead under general anesthesia
Study NCT04356183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SWET: Supervised Weight loss and Exercise Training
Description: Weight loss will occur via a dietitian-led intervention targeting weight loss over 16 weeks, with weekly weigh-ins and group support sessions. Exercise training will consist of three times per week of an interval-based aerobic program plus twice-weekly resistance training. Both weight loss and exercise training will be supervised to maximize safety and adherence.
Study NCT04356183 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CHAT: Counseling Health As Treatment
Description: Control Arm over 16 weeks.
Study NCT06332417 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ba-Duan-Jin Based Deep Breathing Exercises
Description: Pressing Up to the Heavens: Deep inhales while raising arms, promoting lung expansion.~Drawing the Bow to Shoot the Eagle: Stretching exercises to improve flexibility and posture.
Study NCT06332417 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FET (Forced Expiratory Technique)
Description: The forced expiratory technique sometimes referred to as a 'huff', is used to help force secretions (phlegm) up the throat so it can be removed via the mouth without the pain of coughing.
Study NCT05483218 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nocturnal wrist orthosis wearing
Description: Nocturnal wearing of one of the 2 wrist orthosis kind
Study NCT05815979 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: Presentation of the virtual reality glasses and an information meeting will be held for all students in the experimental group, and the working procedure of the virtual reality glasses will be introduced. Afterwards, students will monitor the practice skill at least once using virtual reality glasses. After the completed follow-up, the students will be asked to practice their nasogastric tube application skill on a simple simulation mannequin/model with low reality in the laboratory environment.
Study NCT06405308 — intervention group
Intervention type: PROCEDURE
Intervention: R-NOSES group
Description: robotic natural orifice specimen extraction surgery
Study NCT06405308 — intervention group
Intervention type: PROCEDURE
Intervention: R-TSES group
Description: robotic transabdominal specimen extraction surgery
Study NCT06089785 — intervention group
Intervention type: DEVICE
Intervention: elastography
Description: evaluation of degree of spleen stiffness in liver cell failure patient by elastography.
Study NCT05682222 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: EDP1815
Description: EDP1815 is an essentially non-viable, non-replicating pharmaceutical preparation of a single strain of Prevotella histicola, a naturally occurring human commensal microbe.
Study NCT05682222 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: EDP2939
Description: EDP2939 is a pharmaceutical preparation of extracellular vesicles.
Study NCT05682222 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo oral capsule
Description: Placebo.
Study NCT05168111 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Detect the serum sample
Description: Detect the serum sample
Study NCT05788016 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: opioid taper
Description: The participant will attempt to taper their opioid dose by \~50% during the 4-6 week preoperative period
Study NCT05816499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: Given IV, 10mg/kg Q3W
Study NCT05816499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib
Description: oral，6mg/8mg/10mg qd 2W/3W
Study NCT05816499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Given IV, 60-75mg/m2 Q3W
Study NCT05140824 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride solution
Study NCT05140824 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TJ202 injection
Description: TJ202 injection
Study NCT05191914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide+ Fulvestrant
Description: Drug: Chidamide chidamide 30mg orally，Biw~Drug: Fulvestrant Fulvestrant 500mg i.m. injections every 28 days (Cycle n Day 1) with 1 additional dose on Day 15 of Cycle 1
Study NCT05243693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin
Description: 3 cycles of Brentuximab vedotin and DHAP
Study NCT05439005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Dexmedetomidine+Lidocaine
Study NCT06240416 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low speed drilling without irrigation
Description: Low-speed drilling (50 rpm) irrigation to perform the osteotomy
Study NCT06240416 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High speed drilling with irrigation
Description: High-speed drilling (800 rpm) irrigation to perform the osteotomy
Study NCT05625555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: IV Ketamine infusion 0.5mg/kg over 40 minutes
Study NCT05625555 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: IV Midazolam infusion 30μg/kg over 40 minutes
Study NCT04814199 — intervention group
Intervention type: OTHER
Intervention: Algorithm
Description: Patients will have a printed algorithm to follow while they are in labour with an epidural for pain management.
Study NCT06284824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stryker Triathlon with MAKO Robotic-Arm
Description: Implant is the Stryker Triathlon total knee arthroplasty and the robotic device is the MAKO robotic-arm
Study NCT06284824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DePuy Attune with VELYS Robotic-Assistance
Description: Implant is the DePuy Attune total knee arthroplasty and the robotic device is the VELYS robotic-assistance
Study NCT06415500 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NK042
Description: NK042 intraperitoneal infusion on Days 0,7 and 14.
Study NCT06457906 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Experimental group (SRS/SRT/Hypo-RT)
Description: The prescription dose of SRS/SRT is 18-22Gy in 1 fraction, 27Gy in 3 fractions and 30Gy in 5 fractions. The prescription dose of Hypo-RT is 40Gy in 8 fraction. The prescription dose could be adjusted if lesions are located in brain stem when treat with SRS/SRT/Hypo-RT.
Study NCT06457906 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Controled group (HA-WBRT)
Description: The prescription dose of HA-WBRT is 30Gy in 10 fraction.
Study NCT05300204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-help strategies for depression
Description: Before starting the intervention, the participants are told that they will be shown parts of a website about depression. The participants are instructed to carefully attend to the website (e.g., to read the text precisely, to hear attentively to the podcasts and to view carefully the videos and images on the website). The time window spent for the reception of each part of the website are fixed.~The participants in this intervention group will only be shown parts of the website regarding self-help strategies for depression.
Study NCT05300204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: General information about depression
Description: Before starting the intervention, the participants are told that they will be shown parts of a website about depression. The participants are instructed to carefully attend to the website (e.g., to read the text precisely, to hear attentively to the podcasts and to view carefully the videos and images on the website). The time window spent for the reception of each part of the website are fixed.~The participants in this intervention group will only be shown parts of the website regarding general information about depression
Study NCT05054387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Agalsidase beta
Description: Powder for concentration into a solution Intravenous (IV) infusion
Study NCT05569590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propolis
Description: Vital tooth bleaching will be performed and Propolis as a desensitizing agent will be applied after bleaching to reduce dentine hypersensitivity.
Study NCT05569590 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hydrogen peroxide 35%
Description: hydrogen peroxide 35%
Study NCT05569590 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydrogen peroxide 35%
Description: hydrogen peroxide 35%
Study NCT05569590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: fluoride varnish
Description: fluoride varnish
Study NCT05249517 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education
Description: Pain Neuroscience Education (PNE) is a patient education approach that explains in detail the neurobiology, neurophysiology of pain, and the processing of pain by the nervous system in the management of chronic pain.
Study NCT05249517 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Progressive submaximal exercise program
Description: It has been shown that the long-term results of the use of PNE in addition to physiotherapy are more effective in reducing pain and disability. It has been reported that progressive submaximal exercise program including cervicothoracic strengthening, endurance, flexibility, and coordination exercises has positive effects on chronic neck pain, related disability, quality of life and mood.
Study NCT05149885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SenseGuard monitoring
Description: All subjects that recruited to the study will undergo MCT as usual with the addition of SG measurement after each Methacholine dose and spirometry test.
Study NCT04834089 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AntiSARS-CoV-2 Serum
Description: Stage A: 30 kidney transplanted participants (very high risk), where 15 will received 1 vial (5 mL) and 15 will received 2 vials (10 mL) of serum; Stage B: 30 immunocompetent participants with at least 2 risk factors for severe disease (high risk) who will receive the dose selected by stage A; Stage C: 558 participants, of very high risk and high risk, compared with placebo in allocation 2:1.
Study NCT04834089 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline solution Administration Route: Intravenous
Study NCT04349046 — intervention group
Intervention type: DEVICE
Intervention: Total hip arthoplasty (THA)
Description: Total hip arthroplasty (THA) is a common operative treatment where an arthritic, degenerative or fractured hip joint is replaced with a prosthetic device if conservative options are unable to relieve pain and debilitating symptoms. THA was traditionally performed on patients over 60 years old, but now includes young and active patients, as well as very old ones thanks to the continuous improvement in implant design. Major indications of THA include osteoarthritis, rheumatoid arthritis, avascular necrosis and hip fractures. The THA surgical procedure involves replacing the head of the femur and acetabulum or socket with an artificial prosthesis. This system is composed of a femoral stem that is inserted into the femoral canal, a ball that attaches to the femoral stem, and an acetabular component or shell that replaces the acetabulum.
Study NCT04930575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique
Description: A biomechanical correction approach can lead to the normalization of spinal curvatures and a decrease in the compressional and tensional stress on joints and soft tissues of the body.
Study NCT04930575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Technique
Description: * The patient will be in a supportive low back chair, thus cervical region will be in a vertical position (Weight-bearing position) with the therapist position will be behind the patient.~* Then the therapist will move the spinous process up in the direction that must follow the apophyseal joint plane under treatment, that is, toward the eye ball. While sustaining this pain-free accessory glide, the patient will be instructed to actively perform the physiological movement gradually until the end ROM with over pressure at the end of the range.
Study NCT05348278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Urea cream
Description: apply 10% urea cream at both hands and feet twice daily
Study NCT05204693 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 15 minutes eccentric cycling
Description: The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05204693 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15 minutes eccentric cycling
Description: The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05204693 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 15 minutes concentric (normal) cycling
Description: The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT05204693 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 15 minutes concentric (normal) cycling
Description: The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Study NCT06193109 — intervention group
Intervention type: OTHER
Description: the patients with sepsis and septic shock were performed echocardiography for detecting right ventricular systolic function
Study NCT06113679 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RDX-19
Description: RD-X19 device with a 5 minute, 32 J/cm2 dose, 2X/day, 7 days. Each treatment at least 6 hours apart.
Study NCT06113679 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: RDX-19
Description: RD-X19 device with a 5 minute, 32 J/cm2 dose, 2X/day, 7 days. Each treatment at least 6 hours apart.
Study NCT04599530 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Talaris Demonstrator
Description: The Talaris Demonstrator will be evaluated during daily activities and compared to the current prosthesis